Welcome to our dedicated page for Danaher Corporation SEC filings (Ticker: DHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Danaher Corporation (NYSE: DHR) SEC filings page provides access to the company’s official regulatory documents filed with the U.S. Securities and Exchange Commission. These filings include current reports on Form 8‑K, quarterly reports on Form 10‑Q and other disclosures that detail Danaher’s financial performance, governance changes and capital markets activities as a global life sciences and diagnostics innovator.
Danaher uses Form 8‑K filings to report material events such as quarterly and annual financial results, estimated financial performance ahead of investor conferences, amendments to its by‑laws, share repurchase authorizations and changes in senior leadership or board composition. For example, the company has filed 8‑Ks to furnish earnings press releases and presentation slides, to describe updates to its by‑laws regarding shareholder proposal and nomination procedures, and to outline a share repurchase program authorizing the repurchase of up to 35 million shares of common stock.
The filings also list Danaher’s securities registered under Section 12(b) of the Exchange Act, including its common stock and multiple series of senior notes with various maturities, all traded on the New York Stock Exchange. This information helps investors understand the company’s capital structure and the instruments available in public markets.
Through its periodic reports, Danaher provides detailed financial statements, management’s discussion and analysis, and explanations of non‑GAAP measures such as core sales growth and adjusted diluted net earnings per common share. The company explains how it calculates these measures, why management uses them and how they reconcile to the most directly comparable GAAP figures, including adjustments for amortization of acquisition‑related intangible assets, fair value gains and losses on investments, impairments and tax effects.
On Stock Titan, users can review these SEC filings alongside AI‑powered summaries that highlight key points, such as revenue trends, margin drivers, capital allocation decisions, governance changes and risk disclosures. The platform’s tools can help readers quickly understand the implications of Danaher’s 10‑Q and 10‑K reports, as well as 8‑K items related to dividends, share repurchases, executive transitions and by‑law amendments, while still allowing detailed review of the original documents.
Danaher Corporation granted SVP Strategic Development Bradley R. Gray equity awards on March 1, 2026. He acquired 7,699 employee stock options and 2,849 restricted stock units (RSUs)
Danaher Corporation President & CEO Rainer Blair reported equity awards. On March 1, 2026, he acquired 47,475 employee stock options at an exercise price of $0.00 and 17,566 shares of common stock through a grant.
The filing notes these are restricted stock units payable solely in common stock, with 25% of the RSUs vesting on each of the first four anniversaries of the March 1, 2026 grant date. Fifty percent of the options become exercisable on each of the third and fourth anniversaries of that date. After these awards, Blair directly holds 37,988 common shares, 47,475 options, and indirectly holds 58,255 shares through a trust.
Danaher Corporation executive vice president and CFO Matthew E. Gugino reported equity compensation changes. He received an employee stock option for 10,778 shares at a price of $0.0000 per share and a grant of 3,988 shares of common stock, both classified as grant or award acquisitions on March 1, 2026. A separate disposition of 231 common shares at $210.64 per share was recorded to cover tax obligations, leaving him with 11,401 directly owned common shares. Footnotes note that the restricted stock units vest in four annual installments, while the options become exercisable in two installments on the third and fourth anniversaries of the grant date.
Danaher Corporation Executive Vice President Julie A. Sawyer reported equity compensation awards and a related tax share withholding. On March 1, 2026, she acquired 16,681 employee stock options and 6,172 shares of common stock as grants with no cash paid per share.
The restricted stock units reported as common stock vest 25% on each of the first four anniversaries of March 1, 2026. The stock options become exercisable in two stages, with 50% vesting on each of the third and fourth anniversaries of that same grant date.
Also on March 1, 2026, 1,080 shares of common stock were disposed of at $210.64 per share to satisfy tax withholding obligations, leaving her with 22,221 directly owned common shares after these transactions.
Danaher Corporation SVP of Human Resources Georgeann Couchara reported new equity awards. On March 1, 2026, she acquired 12,831 employee stock options at an exercise price of $0.00 and 4,748 shares of common stock as a grant.
On the same date, 113 shares of common stock were disposed of at $210.64 per share to cover tax obligations through share withholding. After these transactions, she directly owned 8,572 shares of Danaher common stock. The restricted stock units vest in four equal annual installments starting on March 1, 2026, and the options become exercisable in two stages on the third and fourth anniversaries of that date.
Danaher Corporation executive Matthew E. Gugino, EVP & Chief Financial Officer, filed an initial ownership report showing his existing equity interests in Danaher common stock and related compensation plans. The filing lists deferred compensation tied to a Danaher stock fund, multiple employee stock options that vest over several years, and common shares held directly and through a 401(k) plan. The notional deferred compensation shares convert on a one-for-one basis into Danaher common stock under the company’s deferred compensation program.
Danaher Corporation director and executive committee chairman Mitchell P. Rales reported a bona fide gift of 71,648 shares of Danaher common stock, made through the Mitchell P. Rales Family Trust. After this transfer, that trust held 778,352 shares indirectly. The filing also lists other holdings as of the same date, including 53,228 shares held directly by Rales, 801 shares held indirectly through a 401(k) plan, and 26,171,000 shares held indirectly through single-member LLCs owned by a revocable trust for which he is sole trustee and beneficiary. Additional shares are reported in custodial accounts for his daughter, and Rales expressly disclaims beneficial ownership of those daughter-held shares.
Danaher Corporation senior executive reports small share disposition for taxes. SVP of Human Resources Georgeann Couchara reported a tax-withholding disposition of 101 shares of Danaher common stock on February 24, 2026, at a price of $209.19 per share, leaving her with 3,937 directly held shares.
Danaher Corporation senior executive reports small tax-related share disposition. SVP and Chief Science Officer Jose-Carlos Gutierrez-Ramos reported a tax-withholding disposition of 344 shares of Danaher common stock at $209.19 per share. After this transaction, he directly holds 12,655 Danaher common shares.
Danaher Corporation executive Christopher Bouda, VP and Chief Accounting Officer, reported a tax-withholding disposition of 235 shares of common stock on February 24, 2026, at $209.19 per share. This was to satisfy tax obligations and was not an open-market sale.
After this transaction, Bouda directly held 8,090 common shares. He also indirectly held 677.258 common shares through a 401(k) plan, reflecting retirement-plan holdings rather than trading activity.